Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rang in aandelen #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aandeelprijs
$1.06
Laatst gesynchroniseerd: 2021-06-25
Marktkapitalisatie
$110.93K
Verandering (1 dag)
-5.36%
Verandering (1 jaar)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Categorie

Koersgeschiedenis voor Millendo Therapeutics, Inc. (MLND)
Hoogste slotkoers: $1.33 op 2021-06-01

Laagste slotkoers: $8.83 op 2018-12-01
Koersgeschiedenis van Millendo Therapeutics, Inc. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2021 -34.50%
2020 -69.63%
2019 -24.13%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE